Get started
Author

Damacio Ramón Kaimen-Maciel

Observed names: D R Kaimen-Maciel, D. R. Kaimen-Maciel, D.R. Kaimen-Maciel, DAMACIO RAMÓN KAIMEN-MACIEL, DAMÁCIO RAMON KAIMEN-MACIEL, Damacio Kaimen-Maciel, Damacio R Kaimen-Maciel, Damacio R. Kaimen-Maciel, Damacio Ramon Kaimen-Maciel, Damacio Ramon Kaimen-maciel, Damácio Ramon Kaimen-Maciel, Kaimen-Maciel, Damacio, Kaimen-Maciel, Damacio Ramón, Kaimen-Maciel,Damacio Ramón
Observed institutions: Universidade Federal da Bahia, Universidade Estadual de Londrina, Universidade Federal de Sergipe, Universidade Tiradentes, Hospital Geral de Fortaleza, Hospital Universitário Getúlio Vargas
ORCID: 0000-0002-8699-0636
Observed ORCID: 0000-0002-8699-0636
OpenAlex ID: A5042529430
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
2009 · Doralina Guimaraães Brum, Amilton Antunes Barreira, et al. · Multiple Sclerosis Journal · 139
Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
2013 · ANA PAULA KALLAUR, SAYONARA RANGEL OLIVEIRA, et al. · Molecular Medicine Reports · 131
Disability in patients with multiple sclerosis: Influence of insulin resistance, adiposity, and oxidative stress
2014 · Sayonara Rangel Oliveira, Andréa Name Colado Simão, et al. · Nutrition · 100
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale
2012 · Sayonara Rangel Oliveira, Ana Paula Kallaur, et al. · Journal of the Neurological Sciences · 89
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis
2012 · Yara Dadalti Fragoso, Mike Boggild, et al. · Clinical Neurology and Neurosurgery · 78
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
2016 · Ana Paula Kallaur, Sayonara Rangel Oliveira, et al. · Molecular Neurobiology · 75
Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis
2016 · Ana Paula Kallaur, Edna Maria Vissoci Reiche, et al. · Molecular Neurobiology · 69
Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple Sclerosis
2010 · Yára D. Fragoso, Alessandro Finkelsztejn, et al. · CNS Drugs · 66
Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review
2015 · Wildéa Lice de Carvalho Jennings Pereira, Edna Maria Vissoci Reiche, et al. · Journal of the Neurological Sciences · 60
PDF
The Brazilian database on pregnancy in multiple sclerosis
2010 · A. Finkelsztejn, Y.D. Fragoso, et al. · Clinical Neurology and Neurosurgery · 60
Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study
2020 · Leda Mezzaroba, Andrea Name Colado Simão, et al. · Molecular Neurobiology · 52
Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis
2019 · Claudia Mara Ribeiro, Sayonara Rangel Oliveira, et al. · Inflammation Research · 48
Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress
2017 · Sayonara R. Oliveira, Andréa N.C. Simão, et al. · Journal of the Neurological Sciences · 48
Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica
2016 · Wildéa Lice de Carvalho Jennings Pereira, Edna Maria Vissoci Reiche, et al. · Acta Neuropsychiatrica · 47
Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis
2018 · Sayonara Rangel Oliveira, Tamires Flauzino, et al. · Metabolic Brain Disease · 45
Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures
2019 · Tamires Flauzino, Andrea Name Colado Simão, et al. · Metabolic Brain Disease · 39
Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid
2016 · Sayonara Rangel Oliveira, Ana Paula Kallaur, et al. · Psychiatry Research · 36
Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes
2015 · Marcio Francisco Lehmann, Ana Paula Kallaur, et al. · Metabolic Brain Disease · 34
Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis
2016 · Katerine Panichi Zanin Ferreira, Sayonara R Oliveira, et al. · Journal of the Neurological Sciences · 33
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis
2016 · Sayonara R. Oliveira, Ana Paula Kallaur, et al. · Molecular Neurobiology · 32
Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis
2021 · REDONE.br – Neuroimmunology Brazilian Study Group Focused on COVID-19 and MS, Lis Campos Ferreira, et al. · Multiple Sclerosis Journal · 28
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders
2021 · Samira Luisa Apostolos-Pereira, Lis Campos Ferreira, et al. · Neurology Neuroimmunology & Neuroinflammation · 27
PDF
Serum levels of brain-derived neurotrophicfactor correlate with the number of T2 MRI lesions in multiple sclerosis
2011 · E.R. Comini-Frota, D.H. Rodrigues, et al. · Brazilian Journal of Medical and Biological Research · 27
PDF
Fabry's disease as a differential diagnosis of MS.
2006 · D Callegaro, D R Kaimen-Maciel · PubMed · 27
European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil
2013 · Doralina Guimarães Brum, Marcelo Rizzatti Luizon, et al. · PLoS ONE · 24
Works count: 70
Citation count: 1,742
H-index: 24
I10-index: 43
Year
Topic
Type